|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2022
Werner, Rudolf A.; Sayehli, Cyrus; Haenscheid, Heribert; Higuchi, Takahiro; Serfling, Sebastian E.; Fassnacht, Martin; Goebeler, Maria-Elisabeth; Buck, Andreas K. und Kroiss, Matthias
(2022):
Successful combination of selpercatinib and radioiodine after pretherapeutic dose estimation in RET-altered thyroid carcinoma.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 50, Nr. 6: S. 1833-1834
Hahner, Stefanie; Hartrampf, Philipp E.; Mihatsch, Patrick W.; Nauerz, Marc; Heinze, Britta; Haenscheid, Heribert; Fuss, Carmina Teresa; Werner, Rudolf A.; Pamporaki, Christina; Kroiss, Matthias; Fassnacht, Martin; Buck, Andreas K. und Schirbel, Andreas
(2022):
Targeting 11-Beta Hydroxylase With [I-131]IMAZA: A Novel Approach for the Treatment of Advanced Adrenocortical Carcinoma.
In: Journal of Clinical Endocrinology & Metabolism, Bd. 107, Nr. 4, E1348-E1355
2019
Werner, Rudolf A.; Ilhan, Harun; Lehner, Sebastian; Papp, Laszlo; Zsoter, Norbert; Schatka, Imke; Muegge, Dirk O.; Javadi, Mehrbod S.; Higuchi, Takahiro; Buck, Andreas K.; Bartenstein, Peter; Bengel, Frank; Essler, Markus; Lapa, Constantin und Bundschuh, Ralph A.
(2019):
Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy.
In: Molecular Imaging and Biology, Bd. 21, Nr. 3: S. 582-590
2017
Werner, Rudolf A.; Lapa, Constantin; Ilhan, Harun; Higuchi, Takahiro; Buck, Andreas K.; Lehner, Sebastian; Bartenstein, Peter; Bengel, Frank; Schatka, Imke; Muegge, Dirk O.; Papp, László; Zsótér, Norbert; Große-Ophoff, Tobias; Essler, Markus und Bundschuh, Ralph A.
(2017):
Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneity.
In: Oncotarget, Bd. 8, Nr. 4: S. 7039-7049